Price $7.01 |
Market Cap
111.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.55
|
P/S
3.22
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
1.4K
|
FCF
0.0
|
|
Op. Margin
-4.60%
|
Net Margin
-5.60%
|
ROE
-2.70%
|
ROI
-1.40%
|
|
ROA
-2.20%
|
EPS Growth
-529.40%
|
Current Ratio
4.4
|
Debt/Equity
5.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.22 | - | - | 9.8M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.46 | - | - | 83.4M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $16.55 | - | - | 602.6M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.37 | - | - | 12.8M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $0.44 | - | - | 62.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
